A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...
pharmaphorum2d
Sanofi drops lung cancer ADC tusamitamab ravtansine
The drug, which targets carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) on tumour cells, was unable to improve progression-free survival in the CARMEN-LC03 trial in previously ...
Medscape6d
Low-Grade Phyllodes Tumor of the Seminal Vesicle Treated With Laparoscopic Excision
The tumors should not invade the prostate and immunohistochemistry must be negative for prostate tumor markers (PSA and prostate acid phosphatase) and carcinoembryonic antigen. As cystadenoma did ...